August 03, 2026 Inspire Medical Systems Reports Second Quarter 2026 Results and Strategic Growth Plan Inspire Medical Systems reports a 7.6% revenue decline in Q2 2026 but improves cash flow and revises full-year guidance upward. The launch of Project Horizon aims to enhance operational efficiency and generate additional growth.
July 27, 2026 Inspire Medical Systems Welcomes Michael H. Carrel to Board of Directors Inspire Medical Systems has welcomed Michael H. Carrel to its Board of Directors, effective July 20, 2026. His extensive experience in medical devices is expected to drive the company's strategic growth and innovation in solutions for obstructive sleep apnea.
July 24, 2026 Inspire Medical Systems Faces Legal Scrutiny Amid Launch Delays Inspire Medical Systems is facing an ongoing investigation and a class action lawsuit following significant delays in the launch of its Inspire V device. The company has drastically reduced its earnings guidance, raising concerns about its operational integrity and future prospects amidst legal challenges.
July 22, 2026 Inspire Medical Systems Inc. Announces Retirement of Board Member Casey M. Tansey Inspire Medical Systems announces the retirement of Casey M. Tansey from its Board of Directors, effective July 30, 2026. Tansey's 18-year tenure has been instrumental in the company's growth, particularly in obstructive sleep apnea technology. His departure signals new opportunities as Inspire continues to innovate in the healthcare sector.
July 06, 2026 Inspire Medical Systems to Announce Q2 2026 Financial Results Inspire Medical Systems will release its Q2 2026 financial results on August 3, 2026. A conference call will follow, providing investors a chance to engage with management and discuss the company's performance.
July 06, 2026 Inspire Medical Systems Inc. Set to Reveal Q2 2026 Financial Results Inspire Medical Systems, Inc. will release its Q2 2026 financial results on August 3, 2026, followed by a conference call for investors. The company specializes in innovative sleep apnea solutions and is expected to provide valuable insights into its market positioning and growth strategy.
June 29, 2026 Inspire Medical Systems Inc: A Deep Dive into Ongoing Investigations and Regulatory Challenges Inspire Medical Systems Inc. is facing investigations due to significant operational setbacks and an 80% cut in its earnings guidance. The company's leadership is under scrutiny for potential breaches of fiduciary duty amid ongoing legal challenges. Investors are urged to stay informed as the situation develops.
June 16, 2026 Inspire Medical Systems Inc. Showcases Innovations and Clinical Insights at SLEEP 2026 Inspire Medical Systems presented groundbreaking innovations at SLEEP 2026, featuring the Inspire V system and new clinical insights on sleep apnea's impact on cardiovascular health. The company emphasized its commitment to improving patient outcomes through advanced technology and clinical research.
June 12, 2026 Inspire Medical Systems to Showcase Innovations at Wells Fargo MedTech Innovation Spotlight Inspire Medical Systems will present at the Wells Fargo 2026 MedTech Innovation Spotlight, showcasing its innovative solutions for treating obstructive sleep apnea. The event is accessible via live webcast, emphasizing Inspire's commitment to transparency and engagement with stakeholders.
May 04, 2026 Inspire Medical Systems Reports Q1 2026 Financial Results and Adjusts Guidance Inspire Medical Systems announced a 1.6% revenue increase in Q1 2026 despite reimbursement challenges, while improved gross margins and cash flow signal potential for future growth. The company has revised its full-year revenue guidance, reflecting a cautious outlook amid industry uncertainties.
May 04, 2026 Inspire Medical Systems Inc. Reports Q1 2026 Financial Results: Navigating Challenges and Opportunities Inspire Medical Systems reported a 1.6% revenue increase to $204.6 million for Q1 2026, despite facing reimbursement challenges. The company has made strategic investments in sales and marketing while navigating macroeconomic headwinds.
April 29, 2026 Inspire Medical Systems to Showcase Innovations at BofA Securities 2026 Healthcare Conference Inspire Medical Systems will showcase its innovative approach to treating obstructive sleep apnea at the BofA Securities 2026 Healthcare Conference. The presentation on May 13 will be accessible via live webcast, highlighting the company's commitment to improving patient outcomes with its FDA-approved Inspire therapy.
April 06, 2026 Inspire Medical Systems Inc. Set to Release Q1 2026 Financial Results Inspire Medical Systems will report its Q1 2026 financial results on May 4, 2026, followed by a conference call for investors. The call will provide insights into the company's performance and future strategies in the obstructive sleep apnea market.
March 03, 2026 Inspire Medical Systems to Showcase Innovations at KeyBanc Capital Markets Healthcare Forum Inspire Medical Systems is set to showcase its innovative Inspire therapy for obstructive sleep apnea at the KeyBanc Capital Markets Healthcare Forum on March 17, 2026. This presentation marks a significant opportunity for the company to engage with investors and highlight advancements in medical technology.
March 02, 2026 Investigation Launched into Inspire Medical Systems Amid Securities Concerns Kahn Swick & Foti, LLC has initiated an investigation into Inspire Medical Systems following recent disclosures that have raised investor concerns. The inquiry will examine potential breaches of fiduciary duties by the company's leadership, coinciding with a significant reduction in earnings guidance and a related securities class action lawsuit.
February 13, 2026 Inspire Medical Systems Inc. Reports Strong Growth in 2025 Annual Results Inspire Medical Systems Inc. reported a 13.6% revenue increase in 2025, reaching $912 million, bolstered by strong U.S. sales. Despite competition from new treatments, the company remains a leader in obstructive sleep apnea technology, focusing on R&D and market expansion.
February 11, 2026 Inspire Medical Systems Inc. Reports Strong Q4 and Full Year 2025 Financial Results Inspire Medical Systems announced strong financial results for Q4 and full year 2025, driven by the successful launch of the Inspire V system. The company anticipates continued growth, projecting revenue between $950 million to $1 billion for 2026 despite challenges in reimbursement.
February 01, 2026 Inspire Medical Systems Under Investigation Amid Regulatory Concerns Inspire Medical Systems is under investigation due to regulatory concerns surrounding the launch of its Inspire V device, leading to a significant earnings guidance cut. A class action lawsuit has been filed against the company for failing to disclose critical information to investors. Kahn Swick & Foti is leading the investigation into potential breaches of fiduciary duty by the company's executives.
January 22, 2026 Investigation Launched into Inspire Medical Systems: A Deep Dive into the Implications for Shareholders The Law Offices of Frank R. Cruz have launched an investigation into Inspire Medical Systems over potential fiduciary breaches by its board. This follows a drastic earnings revision and a significant stock price drop, raising concerns for investors. The outcome could impact the company's future and investor confidence.
January 12, 2026 Inspire Medical Systems Inc. Reports Strong Revenue Growth and Leadership Transition Inspire Medical Systems reported a 14% revenue increase for 2025 and provided strong guidance for 2026. The company also appointed a new CFO, Matt Osberg, enhancing its leadership for future growth.
January 07, 2026 Inspire Medical Systems Inc. Set to Release Q4 and Full Year 2025 Financial Results Inspire Medical Systems is set to release its Q4 and full year 2025 financial results on February 11, 2026. The announcement will be followed by a conference call where management will discuss performance and strategic developments, offering insights valuable to investors.
January 05, 2026 Inspire Medical Systems Faces Legal Scrutiny Amidst Launch Challenges Inspire Medical Systems is facing a class action lawsuit over allegations of misleading investors about the launch and demand for its Inspire V device. Following significant operational setbacks and weak demand, the company's stock plummeted over 32%. Investors are urged to stay informed as the situation develops.
January 02, 2026 Inspire Medical Systems Faces Securities Fraud Lawsuit Amidst Major Stock Drop Inspire Medical Systems is facing a securities fraud class action lawsuit after significant operational setbacks led to an 80% reduction in earnings guidance and a 32.4% drop in stock price. Shareholders who suffered losses between August 2024 and August 2025 are encouraged to participate in the lawsuit before the January 5, 2026 deadline.
December 31, 2025 Inspire Medical Systems Faces Class Action Lawsuit Amidst Troubling Launch of Inspire V Inspire Medical Systems is facing a class action lawsuit over the troubled launch of its Inspire V device, with allegations of misleading statements and operational failures. Investors are advised to contact legal representatives to discuss their rights, especially following a significant drop in stock prices.
December 29, 2025 Inspire Medical Systems to Present at 44th Annual J.P. Morgan Healthcare Conference Inspire Medical Systems will present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, showcasing their innovative treatments for obstructive sleep apnea. The event emphasizes their commitment to advancing medical technology and improving patient outcomes.
December 21, 2025 Inspire Medical Systems Under Investigation for Securities Violations Inspire Medical Systems is being investigated for securities law violations linked to misleading statements about its Inspire V device launch. The company's stock plummeted over 32% after revealing significant setbacks and a lack of demand for the device, leading to a class action lawsuit. Investors are urged to participate in the legal proceedings as the situation develops.
December 03, 2025 Class Action Lawsuit Filed Against Inspire Medical Systems Inc. Inspire Medical Systems, Inc. faces a class action lawsuit due to alleged misleading statements about its Inspire V therapy system, impacting investors who purchased shares between August 2024 and August 2025. Shareholders are encouraged to register with DJS Law Group for updates and potential participation in the case.
November 18, 2025 Inspire Medical Systems to Showcase Innovations at Piper Sandler Healthcare Conference Inspire Medical Systems will present its groundbreaking Inspire therapy for obstructive sleep apnea at the Piper Sandler Healthcare Conference on December 2, 2025. The event underscores the company's commitment to innovation and transparency in the medical technology sector.
November 18, 2025 Inspire Medical Systems Faces Securities Fraud Lawsuit Following Major Earnings Revision Inspire Medical Systems has been hit by a class action lawsuit following a drastic earnings revision and challenges with its new sleep apnea device. Investors are urged to act before the January 5, 2026 deadline as the company navigates legal and operational issues.
November 18, 2025 Inspire Medical Systems Faces Class Action Lawsuit Amidst Poor Product Demand Inspire Medical Systems is facing a class action lawsuit due to allegations of misleading investors about the demand for its Inspire V device. The lawsuit highlights issues with the product launch and training, leading to significant stock price declines. Investors are urged to act before the January 5, 2026 deadline to assert their rights.
November 17, 2025 Inspire Medical Systems Faces Legal Scrutiny Amidst Disappointing Product Launch Inspire Medical Systems is facing legal scrutiny after a failed product launch for its Inspire V sleep apnea device, leading to a significant stock drop. Investors are urged to join a class-action lawsuit by the January 5, 2026 deadline due to allegations of misleading statements by company executives.
November 14, 2025 Inspire Medical Systems Faces Legal Challenges Amidst Disappointing Product Launch Inspire Medical Systems is facing a class action lawsuit due to alleged securities fraud linked to the troubled launch of its Inspire V sleep apnea device. The company disclosed significant operational issues, leading to an 80% cut in earnings guidance and a drastic stock price decline, raising concerns among investors.
November 14, 2025 Inspire Medical Systems Faces Class Action Lawsuit Amidst Troubling Financial Disclosures Inspire Medical Systems is facing a class action lawsuit due to significant financial disclosures that raised concerns about its operational stability. The lawsuit follows delays in the launch of its Inspire V sleep apnea device and a drastic earnings guidance cut, prompting investors to seek legal recourse.
November 13, 2025 Inspire Medical Systems Faces Class Action Amidst Troubling Earnings Guidance Inspire Medical Systems is facing a class action lawsuit due to disappointing earnings guidance and significant product launch delays for its Inspire V device. Allegations of misleading statements about demand and operational failures have exacerbated investor concerns, leading to a sharp decline in stock value.
November 13, 2025 Inspire Medical Systems Faces Class Action Lawsuit Over Inspire V Launch Inspire Medical Systems is facing a class-action lawsuit for allegedly misleading investors regarding the launch of its Inspire V sleep apnea device. The lawsuit highlights issues such as inventory problems and delayed training, which contributed to poor demand and a significant drop in the company’s stock value following a drastic earnings guidance cut.
November 13, 2025 Inspire Medical Systems Faces Class Action Lawsuit Amid Poor Product Launch Inspire Medical Systems is facing a class action lawsuit due to poor demand and operational issues surrounding the launch of its Inspire V device. Investors allege misleading statements were made, leading to significant financial losses. The lawsuit represents a critical moment for the company and its stakeholders.
November 12, 2025 Inspire Medical Systems Faces Securities Fraud Lawsuit Inspire Medical Systems, Inc. is facing a securities fraud lawsuit alleging misleading statements about its Inspire V device launch. Investors impacted between August 6, 2024, and August 4, 2025, are encouraged to join the class action by January 5, 2026, to seek potential recovery of losses.
November 10, 2025 Inspire Medical Systems Faces Class Action Lawsuit Over Securities Fraud Allegations Inspire Medical Systems is dealing with a class action lawsuit after its stock fell by over 32% following delays in launching the Inspire V sleep apnea device. The lawsuit claims that the company misled investors about the product's readiness, leading to significant financial losses.
November 10, 2025 Inspire Medical Systems Faces Securities Fraud Investigation Amidst Falling Stock Prices Inspire Medical Systems is facing a securities fraud investigation prompted by a significant drop in its stock price following delays in launching its new sleep apnea device. The company's earnings guidance was drastically cut, causing a 32.4% decline in share value. Investors are encouraged to explore their legal options amidst these developments.
November 10, 2025 Securities Fraud Investigation Launched for Inspire Medical Systems, Inc. Inspire Medical Systems is under investigation for potential securities fraud following significant operational challenges and a drastic earnings guidance cut. Stock prices plummeted by over 32% after the company disclosed delays in launching its Inspire V device and issues with inventory management. Investors are encouraged to seek legal counsel if affected.
November 07, 2025 Rosen Law Firm Initiates Class Action Lawsuit Against Inspire Medical Systems Inc. The Rosen Law Firm has initiated a class action lawsuit against Inspire Medical Systems, alleging the company misled investors about the market demand for its Inspire V sleep apnea device. Shareholders affected by these misrepresentations are encouraged to participate, with the firm operating on a no-win, no-fee basis.
November 07, 2025 Inspire Medical Systems Faces Legal Scrutiny Amid Launch Setbacks Inspire Medical Systems is under investigation for potential securities law violations related to the troubled launch of its Inspire V device. The company has faced significant setbacks, including training delays and weak demand, leading to a substantial drop in stock price. Investors should be aware of the upcoming January 2026 deadline for lead plaintiff applications in the class action lawsuit.
November 07, 2025 Inspire Medical Systems Faces Class Action Lawsuit Over Alleged Securities Violations Inspire Medical Systems is currently involved in a class action lawsuit over alleged securities violations related to its Inspire V device. The lawsuit claims the company misled investors about the product's launch, resulting in significant financial losses. Investors affected by these issues are encouraged to seek appointment as lead plaintiffs.
November 06, 2025 Inspire Medical Systems Faces Class Action Lawsuit Amid Product Launch Struggles Inspire Medical Systems is being sued for allegedly defrauding investors regarding the launch of its Inspire V sleep apnea device. The complaint cites misrepresentation of market demand and launch readiness, resulting in a significant stock drop and financial fallout.
November 03, 2025 Inspire Medical Systems Reports Strong Q3 2025 Financial Results and Optimistic Outlook Inspire Medical Systems reported a 10% increase in Q3 2025 revenue, reaching $224.5 million. The company is optimistic about its Inspire V system, maintaining its full-year guidance with projected revenues between $900 million and $910 million.
November 03, 2025 Inspire Medical Systems Inc. Reports Strong Q3 2025 Results Amidst Challenges Inspire Medical Systems Inc. achieved a 14.2% revenue growth in Q3 2025, driven by increased U.S. and international sales. The company continues to invest in R&D and marketing, while facing challenges such as supply chain issues and competitive pressures.
October 27, 2025 Inspire Medical Systems to Showcase Innovations at UBS Global Healthcare Conference Inspire Medical Systems will showcase its innovative solutions for obstructive sleep apnea at the 2025 UBS Global Healthcare Conference. The presentation will highlight their FDA-approved neurostimulation therapy and its impact on patient care.
October 10, 2025 Inspire Medical Systems Inc. Unveils Promising Inspire V Data at ISSS/AAO-HNS Meetings Inspire Medical Systems has announced groundbreaking clinical outcomes for its Inspire V system at the AAO-HNS and ISSS meetings. With a 100% procedure success rate and significant improvements in patient adherence and apnea reduction, the Inspire V is set to revolutionize obstructive sleep apnea treatment.
October 06, 2025 Inspire Medical Systems Set to Announce Q3 2025 Financial Results Inspire Medical Systems will announce its Q3 2025 financial results on November 3, followed by a conference call to discuss performance and developments. The company is a leader in treatments for obstructive sleep apnea, with innovative solutions that promise to enhance patient care.
August 04, 2025 Inspire Medical Systems Inc. Reports Robust Q2 2025 Financial Results Amid Transition to Next-Gen Inspire V System Inspire Medical Systems Inc. reported a revenue increase of 10.8% for Q2 2025, reaching $217.1 million. The launch of the next-gen Inspire V system faced challenges affecting adoption rates, yet the company remains focused on growth and innovation in obstructive sleep apnea treatments.
May 05, 2025 Inspire Medical Systems Inc. Reports Strong Q1 2025 Results Amid Ongoing Challenges Inspire Medical Systems Inc. reported a 22.7% revenue increase in Q1 2025, reaching $201.3 million. Despite ongoing supply chain issues and increasing expenses, the company achieved a net income of $3 million, highlighting resilience amid challenges.
April 01, 2025 Inspire Medical Systems Set to Release Q1 2025 Financial Results Inspire Medical Systems is set to announce its Q1 2025 financial results on May 5, 2025. The company, known for its innovative sleep apnea treatments, will host a conference call to discuss the results and future strategies, providing valuable insights for investors.
March 12, 2025 SWOT Analysis of Inspire Medical Systems Inc. in 2025 This article provides a SWOT analysis of Inspire Medical Systems Inc. as of 2025, highlighting its innovative position in obstructive sleep apnea treatments, as well as challenges such as market acceptance and competition. The analysis emphasizes the need for strategic navigation of its strengths and vulnerabilities in a competitive landscape.
March 06, 2025 Inspire Medical Systems to Showcase Innovations at KeyBanc Capital Markets Healthcare Forum Inspire Medical Systems will present at the KeyBanc Capital Markets Healthcare Forum on March 18, 2025, showcasing its innovative solutions for obstructive sleep apnea. The event will highlight the company's advancements and commitment to minimally invasive treatments, with a live webcast available for all investors and stakeholders.
February 10, 2025 Inspire Medical Systems Inc. 2024 Annual Report: Strong Growth Amid Challenges Inspire Medical Systems' 2024 annual report reveals a 28.5% revenue increase to $802.8 million and a return to profitability with a net income of $53.5 million. The company continues to innovate with new product launches and navigates operational challenges while maintaining strong market presence.
February 10, 2025 Inspire Medical Systems Inc. Reports Strong Financial Results for Q4 2024 and Provides 2025 Outlook Inspire Medical Systems reported a remarkable 25% revenue increase in Q4 2024, with net income rising significantly. Looking ahead, the company anticipates a revenue range of $940M to $955M for 2025, bolstered by strategic expansions and the upcoming Inspire V launch.
November 04, 2024 Inspire Medical Systems Inc. Reports Strong Q3 2024 Results: A New Era for Sleep Apnea Solutions Inspire Medical Systems Inc. showcased remarkable growth in Q3 2024 with a 30.3% revenue increase, reaching $563.1 million. The company’s innovative Inspire system and strategic market expansions position it for continued success in sleep apnea treatment.
August 06, 2024 Inspire Medical Systems Inc. Reports Strong Q2 2024 Results Inspire Medical Systems Inc. posted a 29% revenue increase in Q2 2024, achieving $359.9 million. The company also reported a net income turnaround and upcoming product innovations set to expand its market reach.
May 07, 2024 Inspire Medical Systems Inc. Reports Strong Growth in Q1 2024 Inspire Medical Systems Inc. reported a significant revenue increase of 28.2% in Q1 2024, reaching $164 million. The growth was aided by market expansion and product innovations, although challenges like supply chain disruptions persist. A leadership change is also set to influence the company's future strategy.
